Combating and overcoming drug resistance in cancer

por Price, Douglas K.
Publicado 2014

Molecular drivers of metastatic castrate-resistant prostate cancer: New roads to resistance

por Huang, Phoebe A., Price, Douglas K., Figg, William D.
Publicado 2018

Examining HSD3B1 as a possible biomarker to detect prostate cancer patients who are likely to progress on ADT

por Handy, Whitney F., Schmidt, Keith T., Price, Douglas K., Figg, William D.
Publicado 2020

Drugging the undruggable: activity-based protein profiling offers opportunities for targeting the KLK activome

por Lee, Kristi Y., Chau, Cindy H., Price, Douglas K., Figg, William D.
Publicado 2022

Expression of OATP Family Members in Hormone-Related Cancers: Potential Markers of Progression

por Pressler, Heather, Sissung, Tristan M., Venzon, David, Price, Douglas K., Figg, William D.
Publicado 2011

Targeting the metastatic niche: Single-cell lineage tracing in prime time

por Sommer, Elijah R., Napoli, Giulia C., Chau, Cindy H., Price, Douglas K., Figg, William D.
Publicado 2023

A SNP in CYP2C8 is not associated with the development of bisphosphonate-related osteonecrosis of the jaw in men with castrate-resistant prostate cancer

por English, Bevin C, Baum, Caitlin E, Adelberg, David E, Sissung, Tristan M, Kluetz, Paul G, Dahut, William L, Price, Douglas K, Figg, William D
Publicado 2010

Are race-specific ERCC1 haplotypes in melanoma cases versus controls related to the predictive and prognostic value of ERCC1 N118N?

por Gao, Rui, Reece, Kelie M, Sissung, Tristan, Fu, Samuel H, Venzon, David J, Reed, Eddie, Spencer, Shawn D, Price, Douglas K, Figg, William D
Publicado 2013

Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients

por Pastina, Ilaria, Giovannetti, Elisa, Chioni, Aldo, Sissung, Tristan M, Crea, Francesco, Orlandini, Cinzia, Price, Douglas K, Cianci, Claudia, Figg, William D, Ricci, Sergio, Danesi, Romano
Publicado 2010

Abiraterone induces SLCO1B3 expression in prostate cancer via microRNA-579-3p

por Barbier, Roberto H., McCrea, Edel M., Lee, Kristi Y., Strope, Jonathan D., Risdon, Emily N., Price, Douglas K., Chau, Cindy H., Figg, William D.
Publicado 2021

CYP1B1 variants are associated with prostate cancer in non-Hispanic and Hispanic Caucasians

por Beuten, Joke, Gelfond, Jonathan A.L., Byrne, John J., Balic, Ivana, Crandall, AnaLisa C., Johnson-Pais, Teresa L., Thompson, Ian M., Price, Douglas K., Leach, Robin J.
Publicado 2008

Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer

por Reece, Kelie M, Richardson, Emily D, Cook, Kristina M, Campbell, Tessa J, Pisle, Stephen T, Holly, Alesia J, Venzon, David J, Liewehr, David J, Chau, Cindy H, Price, Douglas K, Figg, William D
Publicado 2014

Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib

por Jain, Lokesh, Sissung, Tristan M, Danesi, Romano, Kohn, Elise C, Dahut, William L, Kummar, Shivaani, Venzon, David, Liewehr, David, English, Bevin C, Baum, Caitlin E, Yarchoan, Robert, Giaccone, Giuseppe, Venitz, Jürgen, Price, Douglas K, Figg, William D
Publicado 2010

Comparison of Eight Technologies to Determine Genotype at the UGT1A1 (TA)(n) Repeat Polymorphism: Potential Clinical Consequences of Genotyping Errors?

por Sissung, Tristan M., Barbier, Roberto H., Price, Douglas K., Plona, Teri M., Pike, Kristen M., Mellott, Stephanie D., Baugher, Ryan N., Whiteley, Gordon R., Soppet, Daniel R., Venzon, David, Berman, Arlene, Rajan, Arun, Giaccone, Giuseppe, Meltzer, Paul, Figg, William D.
Publicado 2020

Finasteride Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial

por Chau, Cindy H., Price, Douglas K., Till, Cathee, Goodman, Phyllis J., Chen, Xiaohong, Leach, Robin J., Johnson-Pais, Teresa L., Hsing, Ann W., Hoque, Ashraful, Tangen, Catherine M., Chu, Lisa, Parnes, Howard L., Schenk, Jeannette M., Reichardt, Juergen K. V., Thompson, Ian M., Figg, William D.
Publicado 2015

Genome‐wide Association Study Identified Chromosome 8 Locus Associated with Medication‐Related Osteonecrosis of the Jaw

por Yang, Guang, Singh, Sonal, McDonough, Caitrin W., Lamba, Jatinder K., Hamadeh, Issam, Holliday, L. Shannon, Wang, Danxin, Katz, Joseph, Lakatos, Peter A., Balla, Bernadett, Kosa, Janos P., Pelliccioni, Gian Andrea, Price, Douglas K., Van Driest, Sara L., Figg, William D., Langaee, Taimour, Moreb, Jan S., Gong, Yan
Publicado 2021

Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population

por Petrovics, Gyorgy, Price, Douglas K., Lou, Hong, Chen, Yongmei, Garland, Lisa, Bass, Sara, Jones, Kristine, Kohaar, Indu, Ali, Amina, Ravindranath, Lakshmi, Young, Denise, Cullen, Jennifer, Dorsey, Tiffany H., Sesterhenn, Isabell A., Brassell, Stephen A., Rosner, Inger L., Ross, Doug, Dahut, William, Ambs, Stefan, Figg, William Douglas, Srivastava, Shiv, Dean, Michael
Publicado 2018

Pilot study of gadoxetate disodium-enhanced mri for localized and metastatic prostate cancers

por Lochrin, Sarah E., Turkbey, Baris, Gasmi, Billel, Schmidt, Keith, Strope, Jonathan D., Chau, Cindy H., Sissung, Tristan M., Price, Douglas K., Cordes, Lisa, Markolovic, Suzana, Wood, Bradford J., Pinto, Peter A., McKinney, Yolanda L., Shih, Joanna H., Levy, Elliot, Madan, Ravi, Dahut, William, Choyke, Peter L., Merino, Maria, Figg, William D.
Publicado 2021

Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case–control study

por Yao, Song, Till, Cathee, Kristal, Alan R., Goodman, Phyllis J., Hsing, Ann W., Tangen, Catherine M., Platz, Elizabeth A., Stanczyk, Frank Z., Reichardt, Juergen K. V., Tang, Li, Neuhouser, Marian L., Santella, Regina M., Figg, William D., Price, Douglas K., Parnes, Howard L., Lippman, Scott M., Thompson, Ian M., Ambrosone, Christine B., Hoque, Ashraful
Publicado 2011